THC Therapeutics, Inc.: M&A transaction — THC Therapeutics acquires SugarTop Buddery in all-share deal valued at ~$3M

THC Therapeutics, Inc.

Acquired 100% of ST Holdings Group (SugarTop Buddery) for 3,000 Series D Preferred shares valued at ~$3M.
SugarTop Buddery generated ~$2.1M in 2024 revenue (peak $4.3M in 2022); 10-year craft cannabis brand.
Founder/CEO Anna Kaplan joins THCT; brand noted for female-founded leadership and music-inspired craft cannabis.
This is THCT's second strategic acquisition in 2025, following The Headquarters Group in June.
THCT expands Oregon operations, targeting a bi-coastal national cannabis platform.

item 1.01 item 2.01 item 3.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.85

THC Therapeutics, Inc. completed an acquisition involving ST Holdings Group, LLC. for 3,000 shares of Series D Preferred Stock (closed 2025-07-07).

Action: acquisition
Counterparty: ST Holdings Group, LLC.
Consideration: 3,000 shares of Series D Preferred Stock
Closing: 2025-07-07

Exact text from the filing

On July 7, 2025 the "Company closed the Share Exchange Agreement and acquired 100% of The Headquarters Group, Inc., an Oregon corporation, and its related subsidiaries, in exchange for 3,000 shares of Series D Preferred stock of the Company.

View on SEC.gov

Browse all m&a transactions →

Source: SEC EDGAR

accession 0001477932-25-005094

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.